C19orf44
Uncharacterized protein C19orf44
Also known as: CS044_HUMAN, FLJ21742
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H6X5
- Gene
- C19orf44
- Ensembl
- ENSG00000105072
- Chromosome
- 19
- Canonical length
- 657 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
No narrative summary is available for C19orf44 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
657 residues, UniProt reviewed canonical sequence.
>Q9H6X5|C19orf44
1 MASARKASRP MRDVFGDFSD VSLEDSTMEE IRNFQISRNL TKIAPGHSRF LKRNQTLDEK
61 HLLLKENPVL GSGPRLASCR PPTTASRIRA NAALMKLAQL ETRIMNRKLQ RNLSDTESDS
121 MTADAGLPKR ADRILSGGAL ELASQNTDKT SQNQARELPV TENNAQNAKV SRFLKKKQAP
181 VENISPEAPA GKERTLQTPK QKEPARTFDS PDSDEEEMKV LLGSLMDSSR EKNTNQGFSS
241 ANVSEEEERK LFSVPSQLRA FTVPSVELSS AKPSQTSHLP TSLAADRTLH STRSRADYPQ
301 SHVSSDTASH TPSVSITGAF SNSVSLKMGH VKLVSSPGRS EAETVDEPVS EGADDSLDEF
361 RINILSLDGL APAVSENSDL EQEEESAQRQ KTAGKIFRAE ASTGQDAPRQ AQARSWASQG
421 KAASAEGDES EVSEHLSASS ASAIQQDSTS SMQPPSEAPM VNTVSSAYSE DFENSPSLTA
481 SEPTAHSKES LDRTLDALSE SSSSVKTDLP QTAESRKKSG RHVTRVLVKD TAVQTPDPAF
541 TYEWTKVASM AAMGPALGGA YVDPTPIANH VISADAIEAL TAYSPAVLAL HDVLKQQLSL
601 TQQFIQASRH LHASLLRSLD ADSFHYHTLE EAKEYIRCHR PAPLTMEDAL EEVNKELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C19orf44 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- testis: 15 nTPM
- ovary: 7.6 nTPM
- pituitary gland: 6.7 nTPM
- choroid plexus: 6.6 nTPM
- cervix: 6.5 nTPM
- fallopian tube: 6.5 nTPM
Single-cell type
- late spermatids: 127 nCPM
- early spermatids: 60 nCPM
- epicardial cells: 32 nCPM
- late primary spermatocytes: 30 nCPM
- cardiomyocytes: 30 nCPM
- ependymal cells: 26 nCPM
Immune cell
- basophil: 3.2 nTPM
- memory B-cell: 1.4 nTPM
- naive B-cell: 1 nTPM
- naive CD8 T-cell: 0.9 nTPM
- neutrophil: 0.8 nTPM
- memory CD4 T-cell: 0.6 nTPM
Brain region
- choroid plexus: 15 nTPM
- medulla oblongata: 13 nTPM
- midbrain: 13 nTPM
- hypothalamus: 12 nTPM
- basal ganglia: 11 nTPM
- amygdala: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.11
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.42
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- Domain of unknown function DUF4614
- Uncharacterized protein C19orf44-like
- Domain of unknown function (DUF4614)
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C19orf44 as an antibody target. Whether an autoantibody or antibody against C19orf44 could matter depends on whether native C19orf44 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C19orf44 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label C19orf44 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...